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a  b  s  t  r  a  c  t
l-asparaginase (EC 3.5.1.1) is an enzyme that catalysis mainly the asparagine hydroly-
sis  in l-aspartic acid and ammonium. This enzyme is presented in different organisms,
such as microorganisms, vegetal, and some animals, including certain rodent’s serum,
but  not unveiled in humans. It can be used as important chemotherapeutic agent for the
treatment of a variety of lymphoproliferative disorders and lymphomas (particularly acute
lymphoblastic leukemia (ALL) and Hodgkin’s lymphoma), and has been a pivotal agent in
chemotherapy protocols from around 30 years. Also, other important application is in food
industry, by using the properties of this enzyme to reduce acrylamide levels in commercial
fried  foods, maintaining their characteristics (color, ﬂavor, texture, security, etc.) Actually,
l-asparaginase catalyzes the hydrolysis of l-asparagine, not allowing the reaction of reduc-
ing  sugars with this aminoacid for the generation of acrylamide. Currently, production of
l-asparaginase is mainly based in biotechnological production by using some bacteria. How-
ever,  industrial production also needs research work aiming to obtain better production
yields, as well as novel process by applying different microorganisms to increase the range
of  applications of the produced enzyme. Within this context, this mini-review presents l-
asparaginase applications, production by different microorganisms and some limitations,
current investigations, as well as some challenges to be achieved for proﬁtable industrial
production.© 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
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acrylamide formation when foods are processed in highan  open acces
ntroduction
-asparaginase aminohydrolase (l-asparaginase, EC 3.5.1.1),
as gained attention in recent years due to its impor-
ant applications, as its use in pharmaceutical industry
s an alternative for treatment of different cancers such
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as acute lymphoblastic leukemia, malignant diseases of
the lymphoid system and Hodgkin’s lymphomas.1 Also,
this enzyme is used in food industry to prevent thetemperatures.2 This use is important because acrylamide
is a neurotoxin classiﬁed as potentially carcinogenic to
humans.3
lsevier Editora Ltda. This is an open access article under the CC
.
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Industrial l-asparaginase production presents some chal-
lenges, such as the search for new microorganisms able to
produce it with less adverse effects. Nowadays, industrial pro-
duction is carried out using bacteria such as Escherichia coli and
Erwinia chrysanthemi.4 However, the enzyme obtained from
prokaryotic microorganisms usually presents some problems
such as hypersensitivity and immune inactivation.5 Within
this context, eukaryotic microorganisms such as ﬁlamentous
fungi6 and yeasts7 have been investigated for this enzymes
production, due to better compatibility with the human sys-
tem.
Currently, new studies have been carried out aiming to
enhance production process and establish new ways for
enzyme synthesis. Thus, some of these aspects are discussed,
besides some generalities regarding l-asparaginase applica-
tions in pharmaceutical and food industries.
Reactions  and  mechanism
The hydrolysis process occurs in two steps through an inter-
mediate: beta-acyl-enzyme (Fig. 1). In the ﬁrst process step,
the nucleophilic residue of the enzyme is activated by a strong
base and attacks the amide carbon atom of l-asparagine (sub-
strate), generating a product beta-acyl-enzyme intermediate.
The second reaction step is an attack on the ester carbon made
by a nucleophile activated by a water molecule.8
This mechanism is comparable to serine-proteases classic
mechanism, whose activities depends of an amino acid group,
classiﬁed as catalytic triads. This catalytic triads is composed
by one nucleophilic amino acid, serine (Ser), one base, histi-
dine (His) and one amino acid with acid characteristic, aspartic
acid (Asp), all connected by hydrogen bonds.8
L-asparaginase has also capacity to catalase other reac-
tions. For example, l-asparaginase produced by Serratia
marcescens is able to hydrolase 5% of l-glutamine when
compared with l-asparaginase hydrolysis. The same effect
occurs to l-asparaginase produced by Escherichia coli and
Erwinia chrysanthemi. Other microorganisms, such as Pseu-
domonas sp. and Acinetobacter glutaminasiﬁcans, synthetize
l-asparaginase with equal asparaginase and glutaminase
activity. In some cases, l-asparaginase starts the l-glutamine
hydrolysis only after complete conversion of l-asparaginase in
aspartic acid. Actually, l-glutamine is a competitive inhibitor
of l-asparagine hydrolysis.12 l-glutamine and l-asparagine
hydrolysis are similar due to the structural similarity from
both amino acids. Therefore, the largest part of microbial l-
asparagine presents cross glutaminase activity, with some
exceptions such as l-asparaginase produced by Wolinella
succinogenes, which do not present l-glutaminase activity.12
Finally, l-asparaginase is also able to hydrolyze -aspartyl pep-
tide amide, however reaction yield is considerably low.13
l-asparaginase  applicationsPharmaceutical  industry:  antineoplastic  action
The l-asparagine enzymatic hydrolysis in l-aspartate and
ammonium was observed in a ﬁrst time by Lang (1904),14 that b i o l o g y 4 7 S (2 0 1 6) 77–85
detected l-asparaginase activity in bovine’s tissues. Results
of this researcher were conﬁrmed by Furth and Friedmann
(1910),15 that detected l-asparagine hydrolase in horse and
pig organs, observing the same amount of l-asparaginase
activity in both animals. Also, Clementi (1922)16 related that
l-asparaginase in guinea pig serum, although antitumor activ-
ity of the enzyme was identiﬁed only some years later. In
addition, Mashburn and Wriston (1964)17 demonstrated that l-
asparaginase of E. coli had inhibitory capacity of tumors in rats.
However, the large interest in enzyme started when Broome
(1965)18 found that the regression lymphosarcoma transplants
in rats treated with guinea pig serum was due to nutritional
dependence on malignant cells of exogenous l-asparagine.
Considering its properties, l-asparaginase has been an
important chemotherapeutic agent used for treatment of
lymphoproliferative and lymphoma diseases. Particularly,
it presents large importance in chemotherapeutic proto-
cols for acute lymphoblastic leukemia (ALL) and Hodgkin’s
lymphomas.19
Cancer cells, mainly lymphatic cells, require high amount
of asparagine for fast and malignant growth. In this way, can-
cer cells requires the amino acid from diet (blood serum)
as well as amino acids produced by themselves. However,
leukemic lymphoblasts and some others tumor cells do not
have or present low quantity of l-asparagine synthetase used
for l-asparagine syntheses. Thus, these malignant cells are
dependent of asparagine from blood serum for their prolifer-
ation and survival.20,21
l-asparaginase hydrolyzes asparagine from blood serum,
leading tumor cells to death by lacking of an essential factor
for protein synthetases (p53-dependent apoptosis). However,
healthy cells are not affected, because they are able to produce
asparagine using l-asparagine synthetase present in enough
quantities (Fig. 2). Considering these concepts, Fig. 2 schemat-
ically shows the antineoplastic action of l-asparaginase.
Food  industry:  acrylamide  formation
Acrylamide (C3H5NO) is also known as 2-propenamide, acrylic
amide, ethylene carboxamide, propenamide, propanoic acid
amide, monomer of acrylamide or acrylic acid amide, pre-
senting 71.08 g/mol of molecular mass.22 Several studies show
that l-asparagine is the main amino acid responsible for acryl-
amide production in fried and baked foods when reducing
sugars are condensed with a carbonyl source. This phe-
nomenon does not occur in boiled food.23
Acrylamide formation has been quite studied in the
last years. Zyzak et al. (2003)24 detected that the amide
chain present in the acrylamide structure is provided from
l-asparagine. Reagents (l-asparagine or reducing sugars)
reduction or removal is one of the evaluated strategies for
decreasing acrylamide quantity in foods. For l-asparagine
reduction, several options have been investigated, such as:
selection of vegetal species with lower level of l-asparagine
in their composition; deletion of important enzymes for l-
asparagine biosynthesis control by suppression of speciﬁc
genes; acid hydrolysis of l-asparagine leading the formation
of aspartic acid and ammonia; and acetylation process of
l-asparagine to form N-acetyl-l-asparagine, preventing the
formation of acrylamide from intermediate N-glycosides.22
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Fig. 1 – General mechanism of l-asparaginase reaction catalyzed. Dashed arrow shows nucleophilic attack.
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In the study of Zyzak et al. (2003),24 authors conﬁrmed that
he use of l-asparaginase enzyme before frying or baking food
rocess could reduce more  than 99% acrylamide level in the
rocessed ﬁnal product. This is because the enzyme reduces
ore  than 88% of the l-asparagine concentration from the ini-
ial feedstock. In last years, other works have dealt with this
pplication of l-asparaginase, that can decrease the negative
ffects of acrylamide containing foods without impair their
haracteristics.3,25–28
roduction  by  different  microorganisms
-asparaginase is present in mammals, birds, plants, yeast,
nd a wide range of bacteria.10,29 Although l-asparaginase
roduction is observed in animals, plants,12,30 the microor-
anisms are considered mainly source for l-asparagine
ynthesis.30,31
The production of this enzyme is mainly proceeded by
ubmerged fermentation.30 Several researchers have stud-
ed the isolation of microbial strains that produce this
mportant enzyme, such as Pseudomonas ﬂuorescens,32 Serra-
ia marcescens,33 Escherichia coli,34 Erwinia carotovora,35 Proteus
Blood
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Fig. 2 – Antineoplastic acti
Source: Based on Van det al. (2004),10 and Shrivastava et al. (2016).11
vulgaris,36 Saccharomyces cerevisiae, Karnatakensis Streptomyces,
Streptomyces venezuelae and several genres of fungi as
Aspergillus, Penicillium and Fusarium.37
Concerning to bacteria, the best producers of l-
asparaginase are members of the Enterobacteriaceae family.30
For example, in pharmaceutical industry, this enzyme is pro-
duced mainly from bacteria such as Escherichia coli and Erwinia
carotova, (also known as Erwinia chrysanthemi), generally used
for leukemia and lymphoma treatment.4 However, most of
these treatments can result in immunological sensitization
(hypersensitivity) and immune inactivation in patients that
receive bacterial enzymes.5 Another issue is that glutaminase
activity generated by these enzymes can cause secondary
effects such as allergic reaction, nausea, pancreatitis, diabetes
and coagulation abnormalities.8,38 Also, most of asparagi-
nases has low stability and catalytic activity, presenting only
active in a narrow pH range.39
Currently, l-asparaginases from E. coli and Erwinia chrysan-
themi (synonymous of Erwinia carotovora)  are the only
preparation available for medical use.12 l-asparaginase from
E. coli produces two types of enzyme, l-asparaginase I (EC1),
found in the cytoplasm and l-asparaginase II (EC2), with
nthetase
L-asp agine
Death cell
All  lymphoblast
biosy    esis
Pr   ein
L-aspartic acid
 acid + NH4+
on of l-asparaginase.
en Berg (2011).12
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periplasmic origin.40 However, only the second one has anti-
cancer activity.41 Some studies describes EC1 as a constitutive
enzyme and EC2 as secreted only as a response to exposure to
low concentrations of nitrogen.8 EC2 has an estimated molec-
ular weight of 141 kDa and its kM is about 12.5 M,  meaning a
high afﬁnity for substrate.42 Its half-life is around 1.24 ± 0.17
days and its optimum pH and temperature are 7–8 and 37 ◦C,
respectively.12,42
As an alternative for treatment of patients allergic to l-
asparaginase from E. coli, l-asparaginase from E. chrysanthemi
(ErA) is used. It has half-life of 0.6 ± 0.13 days, a kM of 18 M,
molecular mass about 140 and 150 kDa, optimal pH 8 and 50 ◦C
as optimal temperature.43,44 The difference between its kM and
that one from E. coli’s l-aspraginase is because glutaminase
activity of ErA is higher.42,45
In recent years, different studies were developed aiming to
ﬁnd this enzyme with improved characteristics compared to
l-asparaginase from E. coli, with economically viable produc-
tion as well as causing minimal collateral effects. Searching
from different l-asparagine sources, speciﬁcally eukaryotic
microorganisms, can lead to enzymes with less adverse
effects and different features, which are advantageous for its
application.46
In the last years, eukaryotic fungi have been investigated
as l-asparaginase source.47 For l-asparaginase production by
fungi, the genera Aspergillus, Penicillium and Fusarium have
been studied.6 Currently, fungal recombinant l-asparaginase
from Aspergillus oryzae and Aspergillus niger has already been
used in food industry for reduction of acrylamide formation
in some foods.28 Moreover, authors have reported positive
results by using endophytic fungi of the genus Colletotrichum,
Eupenicillium, Talaromyces.48,49 Also, positive asparaginolytic
activity were also shown by researchers that used fungi
isolated from marine environments, endophytes seaweed,
of genera Alternaria,  Chaetomium, Cladosporium, Colletotrichum,
Curvularia, Nigrospora,  Paecilomyces, Phaeotrichoconis, Phoma and
Pithomyces.50 Within this context, Table 1 present some works
related to l-asparaginase production by bacteria and fungi.
Also, several studies have shown that Aspergillus genus is
available to produce signiﬁcant amounts of l-asparaginase.
For example, Sarquis et al. (2004)37 presented ﬁlamentous
fungi like Aspergillus tamarii and Aspergillus terreus as produc-
ers of l-asparaginase by submerged fermentation, resulting
in 38 U/L and 58.8 U/L, respectively. Authors concluded that
enzyme production was regulated by the nitrogen source.
Moreover, Balasubramanian et al. (2012),51 in a screening
study of l-asparaginase producers, reported that Aspergillus
terreus was able to produce 9.3 U/mL of enzyme. In other study
of culture conditions optimization (temperature 35 ◦C, initial
pH 6.3, inoculum size 1% (v/v), agitation rate 140 rpm, and
incubation time 58.5 h), Gurunathan and Sahadevan (2012)52
reported l-asparaginase production of Aspergillus terreus by
submerged fermentation, reaching production of 44.38 U/mL.
In another optimization project, but by using Aspergillus
niger, Anjum Zia et al. (2013)53 veriﬁed a l-asparaginase
activity of 2.83 U/ml under submerged fermentation. In that
work, authors observed that glucose concentrations above 1%
inhibited the enzyme production.
Another interesting technique for asparaginase produc-
tion is the solid-state fermentation, that allows the use of b i o l o g y 4 7 S (2 0 1 6) 77–85
agroindustrial residues as substrate or support.30 Within this
context, recently, Dias et al. (2015)76 presented the use of
different organic residues (wheat bran, soybean meal, cot-
tonseed meal and orange peel), evaluating the production of
l-asparaginase from Aspergillus niger. The maximum enzyme
production (94.21 U/g) was obtained after 96 h of fermenta-
tion using mixture of wheat bran (1/3), soybean meal (1/3) and
cottonseed meal (1/3).
In addition, yeasts have been becoming an interesting alter-
native for l-asparaginase production. Some investigations
have reported, e.g., the use of the yeasts Pichia polymorpha and
Candida utilis, for this enzyme production. l-asparaginase of
P. polymorpha showed a kM value of 13.7 mM and optimum pH
6.7.77 On the other hand, the enzyme produced by C. utilis has
kM value of 77 M.78 In a recent study, Soler et al. (2015)7 tested
43 different strains of yeasts, verifying that only strains of
Issatchenkia orientalis and Rhodotorula glutinis showed periplas-
mic  l-asparaginase activity when growth in liquid CD-m. Also,
Sajitha et al. (2015)79 presented an investigation by using an
expression study of gene ansB of E. coli,  which encodes l-
asparaginase enzyme, in yeast. This study was developed on
a new protein expression system based on the yeast Pichia
pastoris. The resulting enzyme was extracellular and showed
activity of 2.5 U/mL at optimum temperature of 37 ◦C. By these
results, authors concluded that this new system of expres-
sion could be effective for production of humanized enzyme
by glycosylation patterns similar to mammals.79
Industrial  production  of  l-asparaginase
For industrial production of l-asparaginase, many  factors
need to be taken into account aiming to a process with
higher yield and economic viability. For example, type and
concentration of carbon and nitrogen sources, pH, aeration,
temperature, fermentation time, and, mainly, the micro-
bial agent, have great inﬂuence in the process.52,80 As
previously reported, several microorganisms are presented
as l-asparaginase producers; however, bacteria E. coli and
E. chrysanthemi are the current main microbial agents for
industrial-scale production in pharmaceutical area, while
the fungus Aspergillus oryzae is the most used in food
industry.30,81 Fig. 3 shows an schematic representation for an
industrial process for l-asparaginase production.
Different types of culture medium have been explored
for l-asparaginase production. However, carbon source and
inductor (nitrogen source) are the more  inﬂuencing com-
ponents in the medium. For example, several studies have
demonstrated that best inductors for reaching high yields are
l-asparagina; 82,83L-glutamine83 and L-proline,37,84–86 and the
most common carbon source is glucose, in addition to alter-
native sources such as starch87 and maltose.82,88
l-asparaginase extraction and puriﬁcation are other pivotal
steps for the production of this enzyme. For example, for phar-
maceutical application, high level of puriﬁcation is needed.
Other important concern is that most of microorganisms pro-Different methods for downstream process are reported
such as centrifugation, ﬁltration, liquid–liquid extrac-
tion, chromatography and protein precipitation. Regarding
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Table 1 – Recent studies about l-asparaginase production by bacteria and eukaryotic fungus.
Microorganism Fermentation type l-asparaginase activity kM (mM) pH T (◦C) Reference
Bacteria
Yersinia
Pseudotuberculosis
Q66CJ
SmF  62.7 U mg−1 0.017 8.0 60 54
Bacillus aryabhattai
ITBHU02
SmF  680.5 U mg−1 0.257 8.5 40 55
Pseudomonas
ﬂuorescens
SmF  168.4 U mL−1 110 8 37 56,57
Bacillus licheniformis
RAM-8
SmF  697.1 U mg−1 0.014 6–10 40 58
Nocardiopsis alba
NIOT-VKMA08
SmF  158.1 U mL−1 0.127 8 37 59,60
Streptomyces noursei
MTCC 10469
SmF 0.803 U mg−1 25 M 7.5 50 61
Pectobacterium
carotovorum
MTCC 1428
SmF 35.24 U mg−1 657 M 8–10 40 44
Streptomyces parvulus
KUA106
SmF  146 U mL−1 25 M 7.5 50 62
Bacillus subtilis
hswx88
SmF  23.8 U mL−1 430 M 7.5 40 63
Streptomyces
ginsengisoli
SmF  3.32 U mL−1 25 M 7.5 30 31
Streptomyces
thermoluteus
NBRC 14270
SmF  68.09 U mg−1 1830 8–9 63.6 64
Photobacterium sp.
J15
–  20 U mg−1 760 7.0 25 65
Pyrococcus furiosus SmF 550 U mg−1 12,000 9.0 85 66
Bacillus licheniformis
MTCC 429
SmF 597.8 U mg−1 0.420 8 37 67
Fungi
Talaromyces pinophilus SmF 145 U mg−1 6.4 8 28 68
Trichoderma viride SmF 78.2 U mg−1 0.003 6.5 37 69
Aspergillus aculeatus SmF 207 U mg−1 12.5 9.0 30 70
Cladosporium sp. SSF 83.3 U mg−1 100 6.3 30 71
Rhizomucor miehei SmF 1985 U mg−1 – 7.0 45 26
Penicillium digitatum SmF 833.15 U mg−1 10 7.0 30 72
Penicillium sp. SmF 13.97 U mg−1 4000 7.0 37 73
Penicillium
brevicompactum
NRC 829
SmF  574.24 U mg−1 1050 8.0 37 74
Mucor hiemalis SmF 69.43 U mg−1 4.3 7 37 75
U, international units for enzyme activity; SmF, submerged fermentation; SSF, solid-state fermentation.
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undustrial production, protein precipitation is an advanta-
eous technique due to features such as ease scale up, with
imple equipment requirements, low costs and possibility to
se large number of precipitants. Additionally, the precipitant
gent can be recycled in the ﬁnal process, reducing the
nvironmental impact associated to its disposal. Actually,
recipitation is one of the ﬁrst steps in the downstream
rocess and it is usually combined with traditional tech-
iques to enhance biomolecules puriﬁcation and process
ield.30 Also, other highlighted step used for high degree of
nzyme purity is chromatography, such as ionic exchange,
fﬁnity chromatography, size exclusion, and gel ﬁltration.71,89
or example, Lopes et al. (2015)30 reported that the most
sed puriﬁcation steps are gel ﬁltration and ion exchangechromatography, which often are preceded by precipitation
with (NH4)2SO4. According to authors, considering 50–80%
of the total production costs of proteins are provided by
extraction and puriﬁcation steps, optimized downstream can
result in signiﬁcant economic viability.
For pharmaceutical applications, a step of conjugation
with polyethylene glycol (PEG), or PEGylation, has been
used to improve the compound biostability and bioavailabil-
ity, inﬂuencing in pharmacokinetics and pharmacodynamics
properties of the enzyme and reducing the immunological
response against this biomolecule.90 However, this step of
PEGylation can also result in loss of biological activity of the
conjugate compared with the native enzyme.91 On the other
hand, this step is not required in food industry application.
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Upstream process
Downstream process
Microorganism
(biocatalyst) Medium
Fermentation
submerged fermentation
or
solid state fermentation
appropriate conditions of
temperature, agitation, aeration
Homogenization, bead
milling, osmotic shock
Liquid-liquid extraction,
chromatography
Filtration, centrifugation,
protein precipitation Separation Residue
ResidueCrude extract
Purification
High purity
L-asparaginase
FormulationPEGylation
freeze-dried
Recycle or
treatment
Cell harvesting
and disruption
ustr
rFig. 3 – Schematic representation for an ind
Freeze-drying is other important step to improve the long
and short-term storage of the enzyme l-asparaginase for-
mulation. It can prevent most water-related reactions by
sublimating water from the frozen product under vacuum,
also allowing sterile drying without heating or chemical ster-
ilization. However, problems related to cold denaturation,
freeze denaturation and osmotic pressure increase due to
dehydration and cryoconcentration.92
Conclusion  and  future  recommendations
l-asparaginase is an interesting enzyme with important appli-
cations in pharmaceutical and food industry. However, its use
in these industrial sectors requires some speciﬁc properties,
as security for use by humans. As chemotherapeutic agent,
an efﬁcient action is required, in addition to reduced adverse
effects, such as hypersensitivity and immune inactivation. In
food, this enzyme helps to decrease the concentrations of
acrylamide (carcinogenic compound for humans) formed in
the process, maintaining their nutritional and sensory prop-
erties. Thus, research work seeking for new l-asparaginases,
mainly produced by eukaryotic microorganisms, instead of
bacterial enzymes currently used, has potential to obtain new
enzymes with desirable properties. These discoveries have to
be followed by an intensive work aiming to increase the pro-
cess productivity to enable and extend the use of this enzyme,
mainly in food industries. Taking this into account, tools of
molecular biology are useful, although even a more  traditional
work of biochemical engineering have not been extensively
related in literature, indicating needs of further works such as
different process conﬁguration evaluation, as well as use of
bioreactors options.ial process for l-asparaginase production.
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